Jones Financial Companies’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$470K Sell
2,715
-325
-11% -$48.2K ﹤0.01% 2238
2026
Q1
$296K Buy
3,040
+2,751
+952% +$244K ﹤0.01% 2249
2025
Q4
$23.2K Buy
289
+65
+29% +$5.44K ﹤0.01% 2868
2025
Q3
$21.8K Buy
224
+66
+42% +$5.32K ﹤0.01% 2756
2025
Q2
$11K Sell
158
-347
-69% -$19.8K ﹤0.01% 2838
2025
Q1
$25.1K Buy
505
+231
+84% +$14.6K ﹤0.01% 2347
2024
Q4
$19.1K Buy
274
+55
+25% +$4.57K ﹤0.01% 2278
2024
Q3
$23.5K Buy
+219
New +$25.6K ﹤0.01% 1899

Other funds holding ACLS

Jones Financial Companies's ACLS Position: Q2 2026 in Review

Jones Financial Companies reduced its Axcelis (ACLS) stake by 11% in Q2 2026, selling an estimated $48.2K and leaving 2,715 shares worth $470K. The position accounts for ﹤0.01% of the portfolio, ranked #2238.

Jones Financial Companies first reported a position in ACLS in Q3 2024 and has held it in 8 quarters since. 443 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • Jones Financial Companies held 2,715 shares of Axcelis worth $470K as of Q2 2026.
  • Jones Financial Companies sold 325 Axcelis shares in Q2 2026, an estimated $48.2K.
  • Axcelis made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #2238 holding.
  • Jones Financial Companies first reported a position in Axcelis in Q3 2024 and has held it in 8 quarters since.
  • 443 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.